Implications of Medicare Coverage for Magnetic Resonance Imaging in Patients With Capped or Epicardial Leads-Reference-Cited by-同舟云学术

Implications of Medicare Coverage for Magnetic Resonance Imaging in Patients With Capped or Epicardial Leads

Published:2018-12-01 Issue:12 Volume:3 Page:1139
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Kramer Daniel B.¹,Lo Bernard²³,Russo Robert J.⁴

Affiliation:

1. The Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

2. The Greenwall Foundation, New York, New York

3. University of California, San Francisco

4. Scripps Research Institute, La Jolla, California

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Medicare’s enduring struggle to define “reasonable and necessary” care.;Neumann;N Engl J Med,2012

2. Coverage of magnetic resonance imaging for patients with cardiac devices: improving the coverage with evidence development program.;Kramer;JAMA Cardiol,2017

3. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator.;Russo;N Engl J Med,2017

4. Safety of magnetic resonance imaging in patients with cardiac devices.;Nazarian;N Engl J Med,2017

5. Outcomes and complications of lead removal: can we establish a risk stratification schema for a collaborative and effective approach?;Fu;Pacing Clin Electrophysiol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Removing Obstacles to Magnetic Resonance Imaging for Patients With a Pacemaker or a Defibrillator;JAMA Cardiology;2021-05-01

2. Informed consent and compulsory medical device registries: ethics and opportunities;Journal of Medical Ethics;2021-02-19

3. Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only—Time to Adapt;JAMA Cardiology;2019-05-01

4. HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer;Clinical and Translational Imaging;2019-02